Abstract:Acute myeloid leukemia (AML) is a group of heterogeneous diseases. Abnormalities in genes that encode transcription factors and tyrosine kinases represent two classes of the most frequently detected genetic events in human AMLs. Recently, a new category of gene mutations associated with epigenetic regulation have also been proposed. Recurrent somatic mutations of DNMT3A were identified in 23 of 112 (20.5%) cases using exome sequencing technique. The DNMT3A mutants showed reduced enzymatic activity or aberrant affinity to histone H3 in vitro. Gene expression profiles and DNA methylation patterns showed some differences between patients with and without DNMT3A mutations. Notably, we found that members of HOXB genes were extensively upregulated with mutations of DNMT3A, and hypomethylation of certain CpG islands in the HOXB locus. DNMT3A mutations enabled 32D cells to acquire growth and survival advantage with and without IL3. Leukemias with DNMT3A mutations constituted a group of poor prognosis with elderly disease onset. These data suggest a contribution of aberrant DNA methyltransferase activity to the pathogenesis of acute monocytic leukemia and provides a useful new biomarker for relevant cases. We performed the study to systemically investigate the frequencies and the prognostic relevance of previously known genetic events and newly established molecular markers in a large series of 1,185 adult AML patients. In particular, we intent to stratify the AML patients who lacked cytogenetic prognostic markers into appropriate prognostic groups. Multivariate analysis identified DNMT3A and MLL mutations as independent factors predicting inferior overall survival (OS) and event free survival (EFS), while bi-allelic CEBPA mutations or NPM1 mutations without DNMT3A mutations conferred a better OS and EFS in whole group and younger patients aged less than 60 years. Further studies will be focused on using different treatment strategies according to AML genotypes. Acute myeloid leukemia (AML) is a group of heterogeneous diseases. Abnormalities in genes that encode transcription factors and tyrosine kinases represent two classes of the most frequently detected genetic events in human AMLs. Recently, a new category of gene mutations associated with epigenetic regulation have also been proposed. Recurrent somatic mutations of DNMT3A were identified in 23 of 112 (20.5%) cases using exome sequencing technique. The DNMT3A mutants showed reduced enzymatic activity or aberrant affinity to histone H3 in vitro. Gene expression profiles and DNA methylation patterns showed some differences between patients with and without DNMT3A mutations. Notably, we found that members of HOXB genes were extensively upregulated with mutations of DNMT3A, and hypomethylation of certain CpG islands in the HOXB locus. DNMT3A mutations enabled 32D cells to acquire growth and survival advantage with and without IL3. Leukemias with DNMT3A mutations constituted a group of poor prognosis with elderly disease onset. These data suggest a contribution of aberrant DNA methyltransferase activity to the pathogenesis of acute monocytic leukemia and provides a useful new biomarker for relevant cases. We performed the study to systemically investigate the frequencies and the prognostic relevance of previously known genetic events and newly established molecular markers in a large series of 1,185 adult AML patients. In particular, we intent to stratify the AML patients who lacked cytogenetic prognostic markers into appropriate prognostic groups. Multivariate analysis identified DNMT3A and MLL mutations as independent factors predicting inferior overall survival (OS) and event free survival (EFS), while bi-allelic CEBPA mutations or NPM1 mutations without DNMT3A mutations conferred a better OS and EFS in whole group and younger patients aged less than 60 years. Further studies will be focused on using different treatment strategies according to AML genotypes.

The polymorphism and whole-genome DNA methylation level of DNMT 1 gene in acute leukemia children

The Methylation Pattern of LRP15 Gene in Acute Leukemia

Study on Methylation of P15ink4b Gene and Its Mechanisms in Patients with Myelodysplastic Syndrome and Leukemia.

Correlation Analysis of DNA Methylation Level and Clinical Characteristics in JMML Patients

[The C46359T Polymorphism of DNMT3B Promoter Gene and Pathogenesis of Acute Leukemia].

[The Expression of DNA Methyltransferase DNMT1, 3A and 3B in Acute Leukemia and Myelodysplastic Syndrome].

[Chemical Exposure, Leukemia Related DNA Methylation Changes and Childhood Acute Leukemia].

Significance of DNA methylation status of runx3 gene promoter region in acute leukemia]

Relationship Between DNA Methylation of P73 Gene and Acute Leukemia of Children

Analysis of Methylation Level and Clinical Characteristics of Juvenile Myelomonocytic Leukemia

Genetic and epigenetic changes contributing to leukemogenesis and prognostic impact in acute myeloid leukemia

Significance of methylation of CpG island in promoter domain of human telomerase reverse transcriptase gene in leukemia in children

The relationship between the methylenetetrahydrofolate reductase C677T gene polymorphism and acute lymphocytic leukemia in children

Methylation of the promoter region of the MTRR gene in childhood acute lymphoblastic leukemia.

Gene expression profiling of the DNMT3A R882 mutation in acute leukemia.

Gene Polymorphisms in the Folate Metabolic Pathway and Risk of Pediatric Acute Lymphoblastic Leukemia: a Case-Control Study in a Chinese Population.

Investigating DNA methylation as a mediator of genetic risk in childhood acute lymphoblastic leukemia

Polymorphisms in Folate-Related Genes: Impact on Risk of Adult Acute Lymphoblastic Leukemia Rather Than Pediatric in Han Chinese

DNA methylation markers in the diagnosis and prognosis of common leukemias

Identification and analysis of methylation signature genes and association with immune infiltration in pediatric acute myeloid leukemia

Aberrant DNA Methylation of Acute Myeloid Leukemia and Colorectal Cancer in a Chinese Pedigree with a MLL3 Germline Mutation